Clinical trial
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
NCT00643617
Study timeline
Study start (actual)2007-10-22Date precision: day
Registry last updated2023-05-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Prostatic Cancerunresolved
Prostatic Neoplasmsunresolved
Prostate Neoplasmsunresolved
Cancer of the Prostateunresolved
Interventions
Sponsors & collaborators
Accuray Incorporatedlead sponsor
Mapped research locations
NashvilleTennessee, United States1San DiegoCalifornia, United States1Oklahoma CityOklahoma, United States1Las VegasNevada, United States1Chapel HillNorth Carolina, United States1Long BeachCalifornia, United States1FresnoCalifornia, United States1Colorado SpringsColorado, United States1MobileAlabama, United States1TylerTexas, United States1PasadenaCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00643617 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.